(Q37980173)

26 August 2017

title

The therapeutic potential of GPR119 agonists for type 2 diabetes (English)

1 reference

26 August 2017

0 references

Takahide Ohishi

1

1 reference

26 August 2017

Shigeru Yoshida

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

3 February 2012

1 reference

Expert Opinion on Investigational Drugs

26 August 2017

published in

1 reference

26 August 2017

volume

21

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

321-328

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Diabetic retinopathy. A clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Pathogenesis of NIDDM. A balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Five stages of evolving beta-cell dysfunction during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Lipotoxicity in human pancreatic islets and the protective effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Identification of G protein-coupled receptor genes from the human genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

G-protein-coupled receptors: new approaches to maximise the impact of GPCRS in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

The role of sulphonylureas in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Minireview: transcriptional regulation in pancreatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Transcription factors regulating beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Pancreatic beta cells require NeuroD to achieve and maintain functional maturity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Cellular and molecular biology of the beta cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing beta TC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

2,5-Disubstituted pyridines as potent GPR119 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Exenatide and weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Liraglutide for weight loss in obese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Free fatty acids and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.657797

10.1517/13543784.2012.657797

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference